Clinical Researcher at the Italian National Institute for Health and Science on Ageing (IRCCS INRCA: https://www.inrca.it), with a backgorund in Biomedical Engineering: Master's degree with honors at Politechnic University of Marche Region (UNIVPM) achieved in 2020.
Member of the Italian Society of Artificial Intelligence in Medicine (SIIAM: https://www.siiam.it/) since 2025.
My research activity is focused on AI algorithms, social robotics, mobile apps, IoT, virtual coaching, virtual reality and other technological solutions for elederly care, as well as healthcare digitalization. Most of my research activities is within European programs (AAL, THCS, HORIZON, and EP PerMed) and Italian National programs. In particular, I'm principal investigator for INRCA of the EU project RENEW (THCS) and responsible of the pilot study, where a newly developed digital twin will be tested for monitoring older hypertensive subjects.
Actively working at INRCA usability lab (YOUSE), where new technologies are adapted to and tested with end users.
Clinical Researcher at the Italian National Institute for Health and Science on Ageing (IRCCS INRCA: https://www.inrca.it), with a backgorund in Biomedical Engineering: Master's degree with honors at Politechnic University of Marche Region (UNIVPM) achieved in 2020.
Member of the Italian Society of Artificial Intelligence in Medicine (SIIAM: https://www.siiam.it/) since 2025.
My research activity is focused on AI algorithms, social robotics, mobile apps, IoT, virtual coaching, virtual reality and other technological solutions for elederly care, as well as healthcare digitalization. Most of my research activities is within European programs (AAL, THCS, HORIZON, and EP PerMed) and Italian National programs. In particular, I'm principal investigator for INRCA of the EU project RENEW (THCS) and responsible of the pilot study, where a newly developed digital twin will be tested for monitoring older hypertensive subjects.
Actively working at INRCA usability lab (YOUSE), where new technologies are adapted to and tested with end users.